JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Topcu, I.
Right arrow Articles by Sakarya, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Topcu, I.
Right arrow Articles by Sakarya, M.
Related Collections
Right arrow Critical Care
Right arrow Pharmacology

Anesth Analg 2006;102:876-881
© 2006 International Anesthesia Research Society
doi: 10.1213/01.ane.0000196506.28780.94


CRITICAL CARE AND TRAUMA

The Effects of Tramadol and Fentanyl on Gastrointestinal Motility in Septic Rats

Ismet Topcu, N. Zeynep Ekici, Rusen Isik, and Melek Sakarya

Department of Anesthesiology and Intensive Care, Celal Bayar University, Manisa, Turkey

Address correspondence and reprint requests to Ismet Topcu, MD, Guzelyurt Mah. Ingolstadt Cad., Anadolu Konutlari No:11, 45030 Manisa, Turkey. Address e-mail to topcuismet{at}yahoo.com.


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
In this study, we investigated the effects of tramadol and fentanyl on gastrointestinal transit (GIT) during acute systemic inflammation in an experimental model of cecal ligation and perforation (CLP). One-hundred-twenty male Swiss-Albino rats were divided randomly into 6 groups: Group I = sham-operated + saline; Group II = sham-operated + fentanyl; Group III = sham-operated + tramadol; Group IV = CLP + saline; Group V = CLP + fentanyl; Group VI = CLP + tramadol. Suspension of charcoal was administered as an intragastric meal to measure the GIT. GIT% (mean ± sd) were 46.1% ± 9.8%, 43.2% ± 9.8%, 45.9% ± 10.2%, 33.2% ± 9.2%, 24.9% ± 4.1%, and 31.8% ± 8.4% in Groups I, II, III, IV, V, and VI, respectively. GIT% was significantly less in Group V than in Groups I, II, III, and IV (P < 0.05). The Group VI mean value was significantly lower than those of Groups I, II, and III (P < 0.05) but not different from those of Groups IV and V (P > 0.05). The antitransit effect of fentanyl was shown to have increased in the experimental sepsis model, but no decrease in GIT was obtained with tramadol. This was thought to be the result of an associated endogenic opioid system activation and receptor upregulation in sepsis.


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Endogenous opioid peptide (EOP) and opioid receptors (OR) are widespread in the mammalian gastrointestinal tract (1,2). EOPs are present in neuronal cell bodies and nerve fibers of the myenteric and submucosal plexus, antral G cells, and enterochromaffin cells in the gut (1). Physiologic roles of the endogenous opioid system (EOS) most probably include the inhibitory control of motility, inhibition of secretion, and the modulation of mechanoreceptor sensitivity in the gut (1,2). Furthermore, it has been verified that tissue injury and peripheral inflammation induce a local increase in EOP and a sensitization or upregulation of OR (3). A comparison of inflammatory and noninflammatory tissues demonstrated that the antinociceptive effect is definitely increased in the presence of inflammation because of peripheral opioid effects (3,4).

EOS may increase the incidence of duodenogastric reflux, vomiting, and pulmonary aspiration as a result of its inhibitory effect on gastric emptying and intestinal motility (5). Furthermore, EOS decreases biliary, pancreatic, and intestinal secretions and delays intestinal motility (6,7). This is especially important in septic patients, who are unable to tolerate absorptive dysfunction or motility disturbances that can accompany enteral nutrition. Consequently, duodenogastric reflux, colonization with enteric Gram-negative pathogens, or translocation may occur (8,9).

Because of the adverse effects of opioids on the gastrointestinal tract, alternative analgesic drugs that do not have significant effects on gastrointestinal motility may offer advantages, especially for patients with sepsis.

Tramadol, a synthetic analog of codeine, is a centrally acting analgesic with a low affinity for µ-opioid receptors. This affinity of tramadol at µ-opioid receptors is some 6000 times less than that of morphine (10). Tramadol also modifies pain transmission by inhibiting neuronal noradrenaline and serotonin reuptake and by stimulating serotonin release (11,12). Tramadol has an analgesic potency similar to that of meperidine, but it is associated with less respiratory depression than conventional opioids (10).

The present study was designed to determine the effects of the µ-opioid agonist fentanyl and the atypical analgesic tramadol on gastrointestinal transit (GIT) during acute systemic inflammation in an experimental model caused by surgical cecal ligation and perforation (CLP).


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
All rats procedures were approved by the Committee on the Humane Care of Laboratory Animals of the Aegean University Faculty of Medicine. One-hundred-twenty male Swiss-albino rats weighing 150–200 g were maintained under standard controlled environmental conditions (temperature, 22°C; humidity, 65%; and light-dark cycle 12 h:12 h) for a minimum of 4 days. All rats were fasted for 18 h before the experiments but were allowed free access to water until 20–30 min before the start of the experiment. All experiments were started between 10 am and 11 am. Rats included in the study were randomly divided into the following 6 groups, each consisting of 20 rats: Group I = sham-operated + saline; Group II = sham-operated + fentanyl; Group III = sham-operated + tramadol; Group IV = CLP + saline; Group V = CLP + fentanyl; Group VI = CLP + tramadol.

Twenty-four hours after sham laparotomy or CLP, and 20 min before the administration of the charcoal marker, fentanyl 0.036 mg/kg or tramadol 3.5 mg/kg was given to rats in Groups II, III, V, and VI. Rats in Groups I and IV received saline injections at the same time. The drugs or saline were injected at a volume of 10 mL/kg subcutaneously. Figure 1 shows the study design on a time axis.


Figure 134
View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. Study design depicted on a time axis. GIT = gastrointestinal transit; CLP = cecal ligation and perforation.

 

A CLP model modified from Wichterman et al. (13) was used to induce sepsis. Rats were anesthetized with halothane, and a 2- to 3-cm midline abdominal incision was performed. After exposure of the cecum, the cecal mesentery was identified and cut through after vascular ligation. The devascularized cecum was punctured with a 20-gauge needle, and a small amount of feces was extracted. The bowel was returned to the abdomen and the abdominal cavity was closed in two layers. A sham operation (abdominal laparotomy and cecal manipulation) was performed on the control rats in Groups I, II, and III.

Body temperature, weight, and mortality were recorded at 24 h before the operation and 6, 12, 18, and 24 h after the operation; a peripheral blood leukocyte count was performed at 24 h before and 12 h and 24 h after the operation. Body temperatures were measured rectally using a digital thermometer (Greisinger Electronic, Bonn, Germany). The differences in body weight at specific time points after surgery were compared to those recorded before surgery.

After dissection of the rats, the degree of peritoneal inflammation was assessed according to Simon et al.'s gradation (14) (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Peritoneal Inflammation Grading

 

GIT was measured by an intragastric meal consisting of an 0.25-mL suspension of charcoal comprising 10% vegetable charcoal in 5% gum acacia (Sigma Chemical Co, St Louis, MO). Rats were killed 20 min after the administration of the charcoal meal. The stomach and small intestine were resected, and the length of the intestine from the pyloric sphincter to the ileocecal junction (A) and the distance traveled by the charcoal through the intestine (B) were measured. GIT was calculated as the percentage of the distance traveled by the charcoal relative to the total length of the small intestine using the following formula:



Formula 1

Statistical analyses were performed using Student's t-test for significant differences between two groups. When multiple groups were compared, one-way analysis of variance was used, followed by a Student-Newman-Keuls test whenever applicable. Variance analysis of survival rate, weight, temperature, and leukocyte counts were performed using a repeated-measurements of analysis of variance test. Peritoneal inflammation was analyzed using the {chi}2 test. A value of P < 0.05 was considered to be significant.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
GIT % values (mean ± sd) were 46.1% ± 9.8%, 43.2% ± 9.8%, 45.9% ± 10.2%, 33.2% ± 9.2%, 24.9% ± 4.1%, and 31.8% ± 8.4% in Groups I, II, III, IV, V, and VI, respectively (Fig. 2). The mean GIT% value in Group V was significantly less than in Groups I, II, III, and IV (P < 0.05). The mean value in Group VI was significantly less than in Groups I, II, and III (P < 0.05) but not statistically different from those of Groups IV and V (P > 0.05).


Figure 234
View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. Gastrointestinal transit (GIT) percentage in groups. Values are mean ± sem. Sh = sham; CLP = cecal ligation and perforation; S = saline; F = fentanyl; T = tramadol. *P < 0.05 when compared with Groups I, II, III, and V; **P < 0.05 when compared with Groups I, II, III, and IV; ***P < 0.05 when compared with Groups I, II, and III.

 

All sham-operated rats survived the experimental procedure until they were killed. In the CLP groups, 20%–30% of the rats died before the planned death 24 h after surgery. Twelve hours after the operation, 4 rats died in Group IV, 5 rats in Group V, and 1 rat in Group VI. After 18 h, one more rat died in Group V, and 3 more rats died in Group VI. Survival rates in the groups are shown in Table 2.


View this table:
[in this window]
[in a new window]
 
Table 2. Survival Rates of CLP Groups

 

Before the experiments, body weight ranged from 150 to 200 g. Mean weight loss in Groups I, II, and III was 8.1 g, 7.8 g, and 7.9 g, respectively, over the first 12 h after surgery. Thereafter, body weight increased in these rats until they achieved their initial weight by the end of the experiment. Mean body weight changes in Groups IV, V, and VI were 20.3 g, 26. 4 g, and 22.3 g at 12 h, respectively. Further loss of body weight was observed at 18 h and 24 h. Body weight changes of the groups are presented in Table 3. A significantly larger loss of body weight was observed in CLP groups at 12 h, 18 h, and 24 h compared with preoperative values.


View this table:
[in this window]
[in a new window]
 
Table 3. Comparison of Changes of Body Weight, Temperature, and Leukocyte Counts

 

Before the experimental procedures, the mean body temperature of all rats was 35.67°C. Temperature measurements in sham-operated rats were approximately stable over the entire experiment. Mean body temperatures are demonstrated in Table 3. A significantly larger loss of body temperature was observed in CLP groups at 12, 18, and 24 h compared with preoperative temperatures.

There was also a decrease in peripheral blood leukocyte counts in septic rats at 12 and 24 h after CLP (Table 3).

Peritoneal inflammation was seen in only one sham-operated rat (Groups I–III), whereas all rats in the CLP groups (Groups IV–VI) had at least an abscess or localized peritonitis. The number of rats with high degrees of peritoneal inflammation was significantly larger in CLP groups than sham groups (P < 0.05) (Table 4).


View this table:
[in this window]
[in a new window]
 
Table 4. Degree of Peritoneal Inflammation

 


    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
In the present study, we evaluated the effects of tramadol and fentanyl on GIT during acute systemic inflammation. We observed that the antitransit effects of fentanyl increased significantly in the presence of systemic inflammation but that no decrease in GIT was obtained with tramadol.

Both synthetic and endogenous opioids delay gastric emptying and GIT without the presence of systemic inflammation (7,15,16). Several studies have demonstrated that both systemic and spinal opioids delay gastric emptying (5,17,18) and that the effects are both peripherally and centrally mediated (19). In our study, although no statistical differences were found between the sham + fentanyl group and the sham + saline group, there was a larger decrease in GIT in the sham + fentanyl group, which was attributed to the effect of the opioid.

In the present study, systemic inflammation was induced by CLP. This is a well-characterized animal model of bacterial peritonitis that mimics many of the features of the human form of septic syndrome (20,21).

All CLP-operated rats demonstrated a pronounced clinical response, including significantly increased weight loss and changes in body temperature and leukocyte count compared with baseline measurements. In addition, mortality in the CLP groups was significantly more frequent than in the sham-operated groups. The differences in the degree of peritoneal inflammation were found to be smaller in sham-operated groups when compared with CLP groups.

In experimental studies, it has been shown that endotoxemia causes dose-dependent changes in jejunal transit time (22) and can markedly delay gastric emptying (23). In the present study, GIT was significantly slower in the CLP + saline group than in the sham-operated + saline group, implying sepsis-induced alterations of intestinal motility. With respect to impaired GIT during sepsis, our present study correlates well with the above-mentioned literature (22,23).

Inflammation sensitizes ORs in the myenteric and submucosal plexuses and in peripheral or central terminals and also increases the effects of exogenously administered µ and {delta} opioids (24). In rats, it has been reported that the inhibitory effect of morphine increases threefold in the presence of intestinal inflammation (25). In another study (26), the same researchers have shown that the GIT-inhibiting effect of fentanyl increases 1.9 times in the presence of intestinal inflammation, indicating EOS activation during local inflammation occurring in the intestinal system. All these studies support the hypothesis that the sensitivity of the ORs increases under conditions of stress. In the present study, GIT decreases were larger in the CLP + fentanyl group than in the sham + fentanyl group. This result suggests that during systemic inflammation, the antitransit effect of opioids also increases, which may be caused by upregulation of EOS in systemic inflammation and in local inflammation. This experimental approach does not allow a quantitative determination of EOP release but, rather, establishes the fact that the antitransit effect of fentanyl increases during systemic inflammation.

A recently published article by Fruhwald et al. (27) showed that endotoxin pretreatment modified peristalsis of the guinea-pig small intestine in vitro over time and that the antipropulsive effect of sufentanil was marginally decreased. Peristalsis was shown to decrease temporarily in rats after treatment with endotoxin. These results seem to contradict our results and those of other studies (24–26). However, in the Fruhwald et al. study, peristalsis was evaluated in vitro. Probably the absence of systemic factors such as vascular disorders and variations in splanchnic circulation, which can inhibit propulsive motility in vivo, are responsible for these contradictory results.

Some studies (28–30) have reported that tramadol has a dose-dependent prolonging effect on GIT, whereas others (31–33) found no effect. But this inhibitory effect of tramadol has been found to be small when compared with other opioids (28).

Wilder-Smith et al. (34) showed that gastric emptying is significantly delayed by morphine in patients who have undergone abdominal surgery, whereas this has not been observed with tramadol. However, both morphine and tramadol have prolonged the orocecal and colonic transit times. It has been stated that direct inhibition of propulsive motility caused by visceral surgery causes delays in colonic transit time. In our study, a statistically insignificant reduction of GIT in the septic group was found with tramadol, whereas fentanyl caused a significant reduction.

In our study, charcoal was used to calculate GIT. This method measures the motor activity of the intestines and also shows total gastric emptying time plus GIT time. Our findings do not give the results of specific regions, such as the stomach or the small or large intestines. With our method, we are not able to reach a conclusion about the colonic transit time. In addition, with regard to the risk of bacterial translocation, the small intestine has long been considered as a reservoir for pathogens, and therefore, assessment of small bowel function might be more important than evaluation of colonic function (35).

In summary, the effects of opioids on gastrointestinal motility and transit time are clinically important. We found that fentanyl caused a statistically significant reduction of GIT, whereas tramadol had no effect on conditions without acute inflammation. Acute systemic inflammation resulted in a significant reduction of GIT. We also found that the antipropulsive effect of fentanyl, a µ-opioid receptor agonist, significantly increased under septic conditions.

Intestinal paresis can have deleterious results, especially in critically ill patients. The results of impaired intestinal motility are intolerance to enteral feeding, increased pulmonary aspiration risk, and colonization of the stomach with enteric Gram-negative organisms. It is important to choose an appropriate analgesic regimen for patients in the intensive care unit. Especially in the presence of sepsis, it is logical and prudent to avoid drugs that may cause intestinal paresis.


    Footnotes
 
Accepted for publication October 17, 2005.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Kromer W. The current status of opioid research on gastrointestinal motility. Life Sci 1989;44:579–89.[ISI][Medline]
  2. Manara L, Bianchetti A. The central and peripheral influences of opioids on gastrointestinal propulsion. Annu Rev Pharmacol Toxicol 1985;25:249–73.[ISI][Medline]
  3. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg 1993;76:182–91.[Abstract/Free Full Text]
  4. Stein C, Millan MJ, Shippenberg TS, et al. Peripheral opioid receptors mediating antinociception in inflammation: evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 1989;248:1269–75.[Abstract/Free Full Text]
  5. Murphy DB, Sutton JA, Prescott LF, Murphy MB. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology 1997;87:765–70.[ISI][Medline]
  6. Dooley CP, Saad C, Valenzuela JE. Studies of the role of opioids in control of human pancreatic secretion. Dig Dis Sci 1988;33:598–604.[ISI][Medline]
  7. Nimmo WS, Heading RC, Wilson J, et al. Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol 1975;2:509–13.[ISI][Medline]
  8. Inglis TJ, Sherratt M, Sproat L, et al. Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung. Lancet 1993;341:911–3.[ISI][Medline]
  9. Hillman KM, Riordan T, O'Farrell SM, et al. Colonization of the gastric contents in critically ill patients. Crit Care Med 1982;10:444–7.[ISI][Medline]
  10. Vickers MD, O'Flaherty D, Szekely SM, et al. Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia 1992;47:291–6.[ISI][Medline]
  11. Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ’atypical' opioid analgesic. J Pharmacol Exp Ther 1992;260:275–85.[Abstract/Free Full Text]
  12. Driessen B, Reimann W, Giertz H. Effect of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 1993;108:806–11.[ISI][Medline]
  13. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 1980;29:189–201.[ISI][Medline]
  14. Simon R, Wetzel W, Winsey K, et al. Supplemental dietary tyrosine in sepsis and acute hemorrhagic shock. Arch Surg 1987;122:78–81.[Abstract]
  15. Asai T, Mapleson WW, Power I. Differential effects of clonidine and dexmedetomidine on gastric emptying and gastrointestinal transit in the rat. Br J Anaesth 1997;78:301–7.[Abstract/Free Full Text]
  16. Sakarya M, Sakarya A, Aydede H, et al. Can naloxone be a prokinetic agent in sepsis? Clin Intensive Care 2001;12:61–5.
  17. Yuan CS, Foss JF. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses. Neuropharmacology 1999;38:425–32.[ISI][Medline]
  18. Lydon AM, Cooke T, Duggan F, Shorten GD. Delayed postoperative gastric emptying following intrathecal morphine and intrathecal bupivacaine. Can J Anaesth 1999;46:544–9.[Abstract/Free Full Text]
  19. Thorn SE, Wattwil M, Lindberg G, Sawe J. Systemic and central effects of morphine on gastroduodenal motility. Acta Anaesthesiol Scand 1996;40:177–86.[ISI][Medline]
  20. Marshall JC, Creery D. Pre-clinical models of sepsis. Sepsis 1998;2:187–97.
  21. Villar J, Ribeiro SP, Mullen JB, et al. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med 1994;22:914–21.[ISI][Medline]
  22. Cullen JJ, Doty RC, Ephgrave KS, et al. Changes in intestinal transit and absorption during endotoxemia are dose dependent. J Surg Res 1999;81:81–6.[ISI][Medline]
  23. Jennings G, Lunn PG, Elia M. The effect of endotoxin on gastrointestinal transit time and intestinal permeability. Clin Nutr 1995;14:35–41.
  24. Pol O, Ferrer I, Puig M. Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice. J Pharmacol Exp Ther 1994;270:386–91.[Abstract/Free Full Text]
  25. Pol O, Planas E, Puig MM. Effects of morphine and liposomal morphine in a model of intestinal inflammation in mice. Pharmacology 1996;53:180–9.[ISI][Medline]
  26. Pol O, Sanchez B, Puig MM. Peripheral effects of opioids in a model of intestinal inflammation in mice. Pharmacology 1996;53:340–50.[ISI][Medline]
  27. Fruhwald S, Herk E, Scholl G, et al. Endotoxin pretreatment modifies peristalsis and attenuates the antipropulsive action of adrenoceptor agonists in the guinea-pig small intestine. Neurogastroenterol Motil 2004;16:213–22.[ISI][Medline]
  28. Crighton IM, Martin PH, Hobbs GJ, et al. A comparison of the effects of intravenous tramadol, codeine, and morphine on gastric emptying in human volunteers. Anesth Analg 1998;87:445–9.[Abstract/Free Full Text]
  29. Planas E, Poveda R, Sanchez S, et al. Non-steroidal anti-inflammatory drugs antagonise the constipating effects of tramadol. Eur J Pharmacol 2003;482:223–6.[ISI][Medline]
  30. Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001;91:23–31.[ISI][Medline]
  31. Murphy DB, Sutton A, Prescott LF, Murphy MB. A comparison of the effects of tramadol and morphine on gastric emptying in man. Anaesthesia 1997;52:1224–9.[ISI][Medline]
  32. Wilder-Smith CH, Bettiga A. The analgesic tramadol has minimal effect on gastrointestinal motor function. Br J Clin Pharmacol 1997;43:71–5.[ISI][Medline]
  33. De Luca A, Coupar IM. Insights into opioid action in the intestinal tract. Pharmacol Ther 1996;69:103–15.[ISI][Medline]
  34. Wilder-Smith CH, Hill L, Wilkins J, Denny L. Effects of morphine and tramadol on somatic visceral sensory function and gastrointestinal motility after abdominal surgery. Anesthesiology 1999;91:639–47.[ISI][Medline]
  35. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract: the undrained abscess of multiple organ failure. Ann Surg 1993;218:111–9.[ISI][Medline]



This article has been cited by other articles:


Home page
GutHome page
E A Mayer, S Bradesi, L Chang, B M R Spiegel, J A Bueller, and B D Naliboff
Functional GI disorders: from animal models to drug development
Gut, March 1, 2008; 57(3): 384 - 404.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Topcu, I.
Right arrow Articles by Sakarya, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Topcu, I.
Right arrow Articles by Sakarya, M.
Related Collections
Right arrow Critical Care
Right arrow Pharmacology


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press